Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical HSCTs From Young Non-first-degree vs Older First-degree Donors in Hematological Malignancies
NCT04547049Phase 3Active, not recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Sep 2020
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in leukemia and myelodysplastic syndrome (MDS) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Overall survival at 2 years. Started Sep 2020; status: active, not recruiting.
02
Conditions
leukemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04547049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04547049.